ALUMINUM  ||| S:0 E:9 ||| NNP
CHLORIDE  ||| S:9 E:18 ||| NNP
EFFECT  ||| S:18 E:25 ||| NNP
ON  ||| S:25 E:28 ||| NNP
Ca2+ ||| S:28 E:32 ||| NNP
, ||| S:32 E:33 ||| ,
Mg ||| S:33 E:35 ||| NNP
( ||| S:35 E:36 ||| -LRB-
2+ ||| S:36 E:38 ||| NNP
) ||| S:38 E:39 ||| -RRB-
-ATPase  ||| S:39 E:47 ||| NNP
ACTIVITY  ||| S:47 E:56 ||| NNP
AND  ||| S:56 E:60 ||| CC
DYNAMIC  ||| S:60 E:68 ||| NNP
PARAMETERS  ||| S:68 E:79 ||| NNP
OF  ||| S:79 E:82 ||| IN
SKELETAL  ||| S:82 E:91 ||| NNP
MUSCLE  ||| S:91 E:98 ||| NNP
CONTRACTION  ||| S:98 E:110 ||| NNP
We  ||| S:110 E:113 ||| PRP
studied  ||| S:113 E:121 ||| VBD
enzymatic  ||| S:121 E:131 ||| JJ
activity  ||| S:131 E:140 ||| NN
and  ||| S:140 E:144 ||| CC
measured  ||| S:144 E:153 ||| VBN
strain-gauge  ||| S:153 E:166 ||| JJ
contraction  ||| S:166 E:178 ||| NN
properties  ||| S:178 E:189 ||| NNS
of  ||| S:189 E:192 ||| IN
the  ||| S:192 E:196 ||| DT
frog  ||| S:196 E:201 ||| FW
Rana  ||| S:201 E:206 ||| FW
temporaria  ||| S:206 E:217 ||| FW
m.  ||| S:217 E:220 ||| FW
tibialis  ||| S:220 E:229 ||| FW
anterior  ||| S:229 E:238 ||| FW
muscle  ||| S:238 E:245 ||| FW
fascicles  ||| S:245 E:255 ||| FW
during  ||| S:255 E:262 ||| IN
the  ||| S:262 E:266 ||| DT
action  ||| S:266 E:273 ||| NN
of  ||| S:273 E:276 ||| IN
aluminum  ||| S:276 E:285 ||| NN
chloride  ||| S:285 E:294 ||| NN
solution ||| S:294 E:302 ||| NN
.  ||| S:302 E:304 ||| .
It  ||| S:304 E:307 ||| PRP
was  ||| S:307 E:311 ||| VBD
shown  ||| S:311 E:317 ||| VBN
that  ||| S:317 E:322 ||| IN
AlCl3  ||| S:322 E:328 ||| CD
solutions  ||| S:328 E:338 ||| NNS
did  ||| S:338 E:342 ||| VBD
not  ||| S:342 E:346 ||| RB
affect  ||| S:346 E:353 ||| VB
the  ||| S:353 E:357 ||| DT
dynamic  ||| S:357 E:365 ||| JJ
properties  ||| S:365 E:376 ||| NNS
of  ||| S:376 E:379 ||| IN
skeletal  ||| S:379 E:388 ||| JJ
muscle  ||| S:388 E:395 ||| NN
preparation  ||| S:395 E:407 ||| NN
in  ||| S:407 E:410 ||| IN
concentrations  ||| S:410 E:425 ||| NNS
less  ||| S:425 E:430 ||| RBR
than  ||| S:430 E:435 ||| IN
10 ||| S:435 E:437 ||| CD
( ||| S:437 E:438 ||| -LRB-
-4 ||| S:438 E:440 ||| NNP
)  ||| S:440 E:442 ||| -RRB-
M  ||| S:442 E:444 ||| NNP
Increasing  ||| S:444 E:455 ||| VBG
the  ||| S:455 E:459 ||| DT
concentration  ||| S:459 E:473 ||| NN
of  ||| S:473 E:476 ||| IN
AlCl3  ||| S:476 E:482 ||| CD
to  ||| S:482 E:485 ||| TO
10 ||| S:485 E:487 ||| CD
( ||| S:487 E:488 ||| -LRB-
-2 ||| S:488 E:490 ||| NNP
)  ||| S:490 E:492 ||| -RRB-
M  ||| S:492 E:494 ||| NNP
induce  ||| S:494 E:501 ||| VB
complete  ||| S:501 E:510 ||| JJ
inhibition  ||| S:510 E:521 ||| NN
of  ||| S:521 E:524 ||| IN
muscle  ||| S:524 E:531 ||| NN
contraction ||| S:531 E:542 ||| NN
.  ||| S:542 E:544 ||| .
A  ||| S:544 E:546 ||| DT
linear  ||| S:546 E:553 ||| JJ
correlation  ||| S:553 E:565 ||| NN
between  ||| S:565 E:573 ||| IN
decrease  ||| S:573 E:582 ||| NN
in  ||| S:582 E:585 ||| IN
Ca2+ ||| S:585 E:589 ||| NNP
, ||| S:589 E:590 ||| ,
Mg ||| S:590 E:592 ||| NNP
( ||| S:592 E:593 ||| -LRB-
2+ ||| S:593 E:595 ||| NNP
) ||| S:595 E:596 ||| -RRB-
-ATPase  ||| S:596 E:604 ||| JJ
activity  ||| S:604 E:613 ||| NN
of  ||| S:613 E:616 ||| IN
sarcoplasmic  ||| S:616 E:629 ||| JJ
reticulum  ||| S:629 E:639 ||| NN
and  ||| S:639 E:643 ||| CC
the  ||| S:643 E:647 ||| DT
investigated  ||| S:647 E:660 ||| JJ
concentrations  ||| S:660 E:675 ||| NNS
range  ||| S:675 E:681 ||| VBP
of  ||| S:681 E:684 ||| IN
aluminum  ||| S:684 E:693 ||| NN
chloride  ||| S:693 E:702 ||| NN
was  ||| S:702 E:706 ||| VBD
observed ||| S:706 E:714 ||| VBN
.  ||| S:714 E:716 ||| .
The  ||| S:716 E:720 ||| DT
reduction  ||| S:720 E:730 ||| NN
in  ||| S:730 E:733 ||| IN
the  ||| S:733 E:737 ||| DT
dynamic  ||| S:737 E:745 ||| JJ
contraction  ||| S:745 E:757 ||| NN
performance  ||| S:757 E:769 ||| NN
and  ||| S:769 E:773 ||| CC
the  ||| S:773 E:777 ||| DT
decrease  ||| S:777 E:786 ||| NN
Ca2+ ||| S:786 E:790 ||| NN
, ||| S:790 E:791 ||| ,
Mg ||| S:791 E:793 ||| NNP
( ||| S:793 E:794 ||| -LRB-
2+ ||| S:794 E:796 ||| NNP
) ||| S:796 E:797 ||| -RRB-
-ATPase  ||| S:797 E:805 ||| JJ
activity  ||| S:805 E:814 ||| NN
of  ||| S:814 E:817 ||| IN
the  ||| S:817 E:821 ||| DT
sarcoplasmic  ||| S:821 E:834 ||| JJ
reticulum  ||| S:834 E:844 ||| NN
under  ||| S:844 E:850 ||| IN
the  ||| S:850 E:854 ||| DT
effect  ||| S:854 E:861 ||| NN
of  ||| S:861 E:864 ||| IN
the  ||| S:864 E:868 ||| DT
investigated  ||| S:868 E:881 ||| JJ
AlCl3  ||| S:881 E:887 ||| CD
solution  ||| S:887 E:896 ||| NN
were  ||| S:896 E:901 ||| VBD
minimal  ||| S:901 E:909 ||| JJ
in  ||| S:909 E:912 ||| IN
pre-tetanus  ||| S:912 E:924 ||| JJ
period  ||| S:924 E:931 ||| NN
of  ||| S:931 E:934 ||| IN
contraction ||| S:934 E:945 ||| NN
.  ||| S:945 E:947 ||| .
